NIH Reporter #5K99DA060948-02

Research Grant for Neurobehavioral Markers in Opioid Use Disorder (NIDA)

This opportunity is a research grant solicitation from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, focused on opioid use disorder: - Government Buyer: - National Institute on Drug Abuse (NIDA), National Institutes of Health - Project to be conducted at Icahn School of Medicine at Mount Sinai, New York, NY - OEMs and Vendors: - No specific OEMs or commercial vendors are named, as this is a research grant - Products/Services Requested: - Research services involving longitudinal assessment, neuroimaging, and computational modeling - Focus on identifying neurobehavioral biomarkers to predict craving and relapse in opioid use disorder - No physical products or equipment specified - Unique or Notable Requirements: - Emphasis on naturalistic, longitudinal, and computational approaches - Study to be conducted during inpatient opioid use disorder treatment - Classified under Drug Abuse and Addiction (CFDA 93.279) - Research must address motivational control and relapse prediction using advanced scientific tools

Description

This NIH research grant opportunity focuses on studying motivational control during inpatient opioid use disorder treatment using naturalistic, longitudinal, and computational tools. The project aims to identify neurobehavioral biomarkers of craving and relapse to help address the opioid epidemic. The research involves longitudinal assessment, neuroimaging, and computational modeling. The application deadline is May 26, 2026.

View original listing